Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Diacerein (Primary) ; Glucosamine/chondroitin sulfate
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms KAPS
- 07 Jun 2017 Biomarkers information updated
- 09 Mar 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2017.
- 24 Feb 2016 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov.